![Graham Cooper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graham Cooper
Director/Board Member at
BEAM THERAPEUTICS INC.
Net worth: - $ as of 2026-05-30
Profile
Graham K.
Cooper is currently an Independent Director at Beam Therapeutics, Inc. since 2019 and Chief Financial Officer at Tavo Biotherapeutics, Inc. Former positions include Executive Chairman at Applied Molecular Transport, Inc. from 2022 to 2023, Chairman at Kezar Life Sciences, Inc. from 2022 to 2026, Director-Health Care Investment Banking at Deutsche Bank Securities, Inc. from 1997 to 2006, Independent Director at Celladon Corp.
from 2013 to 2016, Director at Bioniz Therapeutics, Inc., Independent Director at Unity Biotechnology, Inc. from 2017 to 2022, Chief Financial Officer & EVP-Business Development at Geron Corp.
in 2012, Chief Financial Officer, Treasurer & Senior VP at Orexigen Therapeutics, Inc. in 2011, CFO, CAO, Head-Investor & Media Relations at Receptos LLC from 2014 to 2015, Accountant at Deloitte & Touche LLP from 1992 to 1995, and Chief Operating, Financial & Accounting Officer at Assembly Biosciences, Inc. from 2018 to 2019.
Education includes undergraduate studies at the University of California, Berkeley and an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-02 | 0 ( -.--% ) | - $ | 2026-05-30 |
Graham Cooper active positions
| Companies | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director/Board Member | 2019-10-09 |
Former positions of Graham Cooper
| Companies | Position | End |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Chairman | 2026-05-10 |
| APPLIED MOLECULAR TRANSPORT INC. | Chairman | 2023-03-07 |
| UNITY BIOTECHNOLOGY, INC. | Director/Board Member | 2022-05-24 |
| ASSEMBLY BIOSCIENCES, INC. | Director of Finance/CFO | 2019-03-31 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Director/Board Member | 2016-02-29 |
Training of Graham Cooper
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Bioniz Therapeutics, Inc.
 Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Assembly Biosciences, Inc.
 Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
- Stock Market
- Insiders
- Graham Cooper
